BC Centre for Excellence in HIV/AIDS study reveals Treatment as Prevention® combined with targeted Pre-Exposure Prophylaxis can STOP HIV/AIDS®

By /

The BC Centre for Excellence in HIV/AIDS (BC-CfE) has released a new research study showing that the made-in-BC HIV Treatment as Prevention® (TasP® ) strategy coupled with Pre-Exposure Prophylaxis (PrEP) has dramatically reduced premature HIV/AIDS-related deaths and new HIV infections in British Columbia, Canada.

The study, published in Lancet HIV, looked at the impact of three milestones in the fight against HIV – the introduction of highly effective antiretroviral therapy (ART) in 1996, TasP® in 2010, and PrEP in 2018.
ART suppresses the amount of HIV in biological fluids, such as semen or blood, to undetectable levels. As a result, People Living with HIV (PLWH) are no longer infectious and can enjoy a near normal lifespan, free of AIDS. TasP® expands access to free ART to all people immediately after an HIV diagnosis. PrEP refers to the use of two antiretroviral drugs taken daily to prevent HIV infections among individuals at high risk of contracting HIV.

Read the full story

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search